João Eurico Fonseca

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Josef S Smolen, Robert Landewé, Sytske Anne Bergstra et al. · Annals of the Rheumatic Diseases · 2022 · 1.8K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

2016 update of the EULAR recommendations for the management of early arthritis

Bernard Combe, Robert Landewé, C. Daïen et al. · Annals of the Rheumatic Diseases · 2017 · 612 citations · Full text

Medicine, Clinical Sciences, Early Detection +10

Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open-label, phase 4 randomised controlled trial

Frances Humby, Patrick Durez, Maya H Buch et al. · The Lancet · 2021 · 315 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +17

EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis

H.W. van Steenbergen, Daniel Aletaha, Liesbeth J J Beaart-van de Voorde et al. · Annals of the Rheumatic Diseases · 2016 · 312 citations · Full text

Medicine, Internal Medicine, Autoimmunity +11

Rituximab versus tocilizumab in rheumatoid arthritis: synovial biopsy-based biomarker analysis of the phase 4 R4RA randomized trial

Felice Rivellese, Anna E. A. Surace, Katriona Goldmann et al. · Nature Medicine · 2022 · 279 citations · Full text

Life Sciences, Immunology, Internal Medicine +17